Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
105.3 USD | -0.59% | -5.55% | -4.36% |
Apr. 18 | Correction to Health Care Roundup Article | DJ |
Apr. 18 | RBC Lowers Price Target on Abbott Laboratories to $125 From $128, Keeps Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.36% | 184B | |
-3.87% | 105B | |
-4.38% | 67.09B | |
+8.23% | 51.61B | |
+15.54% | 47.55B | |
-4.00% | 39.95B | |
+7.16% | 27.62B | |
-12.48% | 25.74B | |
-1.68% | 25.62B | |
+9.50% | 24.93B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- Abbott Laboratories : UBS Adjusts Abbott Laboratories' PT to $131 From $127, Citing 'Continued Sequential Progress in the Base Business;' Buy Rating Kept